ATRA
Price
$9.43
Change
+$0.08 (+0.86%)
Updated
Oct 22 closing price
Capitalization
94.66M
20 days until earnings call
Intraday BUY SELL Signals
MOLN
Price
$3.61
Change
-$0.01 (-0.28%)
Updated
Oct 22, 11:34 AM (EDT)
Capitalization
138.66M
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATRA vs MOLN

ATRA vs MOLN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ATRA vs. MOLN commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a StrongBuy and MOLN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ATRA with price predictions
Oct 22, 2026

ATRA in upward trend: 10-day moving average moved above 50-day moving average on October 13, 2026

The 10-day moving average for ATRA crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 63 cases where ATRA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on ATRA as a result. In 74 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for ATRA just turned positive on October 21, 2026. Looking at past instances where ATRA's MACD turned positive, the stock continued to rise in 41 of 48 cases over the following month. The odds of a continued upward trend are 85%.

ATRA moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRA advanced for three days, in 231 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

ATRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for ATRA entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.559) is normal, around the industry mean (2.973). P/E Ratio (-6.163) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (22.883) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ATRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for MOLN with price predictions
Oct 21, 2026

MOLN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 13, 2026

MOLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 29 of 38 cases where MOLN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 69 cases where MOLN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

Following a +4.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOLN advanced for three days, in 131 of 186 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MOLN as a result. In 104 of 127 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

MOLN moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MOLN crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 68%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MOLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

The Aroon Indicator for MOLN entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.369) is normal, around the industry mean (2.988). P/E Ratio (-2.681) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (158.730) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. MOLN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MOLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATRAMOLN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 3 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 9 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
80%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ATRA: $9.43 vs. MOLN: $3.62)
Brand notoriety: ATRA and MOLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 48% vs. MOLN: 347%
Market capitalization -- ATRA: $94.66M vs. MOLN: $143.26M
ATRA [@Biotechnology] is valued at $94.66M. MOLN’s [@Biotechnology] market capitalization is $143.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 1 FA rating(s) are green while MOLN’s FA Score has 1 green FA rating(s).

  • ATRA’s FA Score: 1 green, 4 red.
  • MOLN’s FA Score: 1 green, 4 red.
According to our system of comparison, ATRA is a better buy in the long-term than MOLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 6 TA indicator(s) are bullish while MOLN’s TA Score has 3 bullish TA indicator(s).

  • ATRA’s TA Score: 6 bullish, 3 bearish.
  • MOLN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ATRA is a better buy in the short-term than MOLN.

Price Growth

ATRA (@Biotechnology) experienced а -2.28% price change this week, while MOLN (@Biotechnology) price change was +2.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.

Reported Earning Dates

ATRA is expected to report earnings on Nov 11, 2026.

MOLN is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ATRA
Daily Signal:
Gain/Loss:
MOLN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with PHAT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then PHAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+0.86%
PHAT - ATRA
36%
Loosely correlated
-0.28%
LXEO - ATRA
33%
Loosely correlated
-3.67%
INVA - ATRA
33%
Poorly correlated
+0.72%
AUTL - ATRA
31%
Poorly correlated
-2.47%
MOLN - ATRA
31%
Poorly correlated
+3.31%
More

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with FTH. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then FTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
-2.43%
FTH - MOLN
39%
Loosely correlated
-1.06%
SLDB - MOLN
36%
Loosely correlated
+0.16%
RCKT - MOLN
33%
Poorly correlated
-5.98%
ATRA - MOLN
31%
Poorly correlated
+2.07%
AXON - MOLN
29%
Poorly correlated
+2.54%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VMAX66.442.37
+3.70%
Hartford US Value ETF (VMAX)
BRW5.890.04
+0.68%
Saba Capital Income & Opportunities Fund
CORN17.78-0.20
-1.11%
Teucrium Corn Fund (CORN)
QDPL45.88-0.54
-1.16%
Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF (QDPL)
LDEM56.99-1.50
-2.56%
iShares ESG MSCI EM Leaders ETF (LDEM)